Robust NFT, neurodegeneration, atrophy, and motor deficits are typically achieved with transgenic overexpression of mutations on the MAPT gene (P301L, P301S) that cause frontotemporal lobar degeneration (FTLD) [115]. The gene discussed is MAPT; the disease is frontotemporal dementia.